Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study

27 Nov 2020

Abstract excerpt

Summary Background Fatty liver disease (FLD) is the most common cause of liver dysfunction in developed countries. There is great interest in developing clinically valid and minimally invasive biomarkers to enhance early diagnosis of FLD. Aim To investigate the potential of circulatory microRNAs (miRNAs) as biomarkers of FLD at the population level. Methods Plasma levels of 2083 miRNAs were measured by RNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Liver Disease Diagnosis and Treatment
Share to Liver physiology and pathology
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33244812
DOI: 10.1111/apt.16177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam studyPMID 33244812Read ↗

MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectivesSemantic proximity Read ↗

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver diseaseSemantic proximity Read ↗

Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessmentSemantic proximity Read ↗

The Role of miRNAs in the Pathophysiology of Liver Diseases and ToxicitySemantic proximity Read ↗

MicroRNAs in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive reviewSemantic proximity Read ↗

Plasma proteomic signature of fatty liver disease: The Rotterdam StudySemantic proximity Read ↗

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis.Semantic proximity Read ↗

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevanceSemantic proximity Read ↗

Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLDSemantic proximity Read ↗

miRNAs in non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.